This article was originally published in The Tan Sheet
Eleven proposed monographs for dietary supplements have been released for public comment, the U.S. Pharmacopeia states Nov. 15. Six turmeric-related monographs, three soy isoflavones monographs and two monographs for single ingredient amino acid formulations contain specific and validated analytical methods that will ensure the identify of the articles and protect consumers and industry from low-quality and adulterated products, USP says. Separately, USP announces Nov. 12 that it has completed a review of IVC Industries' B-50 Tablets and concluded the product does contain the amount of folic acid stated on its label and does meet USP dissolution requirements. USP conducted its assessment after ConsumerLab.com identified B-50 tablets as one of 10 multivitamins that do not contain label amounts of folic acid. B-50 Tablets are part of USP's Dietary Supplement Verification Program and carries the USP Verified mark...
You may also be interested in...
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.
Pacific Biosciences of California and Aziyo Biologics both acquire new finance chiefs; Illumina hires a new chief marketing officer; WishBone Medical president moves over to take helm at Electromedical Products International; and more.